CSIMarket
 
Phibro Animal Health Corporation  (PAHC)
Other Ticker:  
 
 
Price: $12.3400 $0.25 2.068%
Day's High: $12.52 Week Perf: -2.14 %
Day's Low: $ 12.05 30 Day Perf: 3.26 %
Volume (M): 335 52 Wk High: $ 15.98
Volume (M$): $ 4,133 52 Wk Avg: $13.04
Open: $12.05 52 Wk Low: $9.40



 Market Capitalization (Millions $) 500
 Shares Outstanding (Millions) 41
 Employees 1,400
 Revenues (TTM) (Millions $) 980
 Net Income (TTM) (Millions $) 15
 Cash Flow (TTM) (Millions $) -35
 Capital Exp. (TTM) (Millions $) 37

Phibro Animal Health Corporation
Phibro Animal Health Corporation is a world renowned animal health and nutrition company that focuses on the development, manufacturing and marketing of a wide range of innovative animal health products for livestock, poultry, aquaculture and pet industries worldwide.

The company was founded in 1946 and has been steadily expanding its operations to reach a global network of customers and partners through its subsidiaries in the Americas, Europe, the Middle East, and Asia.

Phibro Animal Health is organized into three main business segments: Animal Health, Nutrition, and Performance Products. Under the Animal Health segment, the company provides veterinary products and solutions such as antibiotics, vaccines, and parasiticides that help improve animal health and productivity.

The company's Nutrition segment offers various premixes, concentrates, and feed additives designed to enhance the nutritional value of animal feed and improve the performance of livestock and aquaculture.

Under the Performance Products segment, Phibro Animal Health provides non-antibiotic growth promoters, mold inhibitors, and other additives that help enhance animal health and growth without contributing to antibiotic resistance.

Phibro Animal Health boasts a vast portfolio of more than 2,500 products that cater to a vast array of animal species, including cattle, swine, poultry, fish, pets, among others. The company's focus on research and development has resulted in many groundbreaking products that have revolutionized the animal health and nutrition industry.

Phibro Animal Health Corporation operates under a core set of values that prioritize animal health, customer satisfaction, and employee well-being. The company is committed to sustainability and ethical business practices that ensure the long-term well-being of the environment and communities where it operates.

Overall, Phibro Animal Health Corporation is a reliable and innovative company that provides top-quality animal health and nutrition products and solutions that help farmers, ranchers, and businesses maximize animal health and productivity while optimizing profitability.


   Company Address: Glenpointe Centre East, 3rd Floor Teaneck 7666 NJ
   Company Phone Number: 329-7300   Stock Exchange / Ticker: NASDAQ PAHC
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Phibro Animal Health Corporation

Headline: Phibro Animal Health Corporation Faces Share Drop Amidst Challenging Financial Results

Phibro Animal Health Corporation, a major player in the pharmaceutical preparations industry, has seen a decline in its shares over the past week. The drop of -4.88% in share price brings the overall decrease to -9.38% during the first quarter of 2024. Additionally, the company's shares are trading only 14% above its 52-week low, indicating a potential cause for concern among investors.
The financial results of the company further highlight some challenges it has faced. Although Phibro Animal Health Corporation experienced a modest revenue advance of 2.032% in the October to December 2023 period, it failed to prevent a significant income reduction of -83.33% compared to the same reporting period the previous year. The company's revenue during this period amounted to $249.62 million, with earnings per share (EPS) at $0.03.

Phibro Animal Health Corporation

Phibro Animal Health Corporation Faces Deficit in First Quarter 2024, Highlighting Financial Challenges

Phibro Animal Health Corporation (PAHC), a leading provider of animal health and nutrition products, recently reported its financial results for the first quarter of 2024. Unfortunately, the company experienced a slip into a shortfall of $-0.20 per share compared to $0.10 per share in the same quarter of the previous year. Furthermore, the earnings per share fell from $0.28 in the previous quarter.
The revenue also took a hit, decreasing by -0.772% to $230.73 million from $232.52 million in the comparable quarter of the previous year. Sequentially, revenue deteriorated even further, declining by -9.305% from $254.40 million. This decline in top-line performance is in stark contrast to the remainder of the Major Pharmaceutical Preparations sector, which managed to post a revenue gain during the same period.
For the first quarter of 2024, Phibro Animal Health Corporation recorded a net shortfall of $-8.015 million, instead of net earnings of $3.856 million in the same quarter a year before. It is worth mentioning that PAHC's stockpiles have increased due to the seasonal nature of the company's business, reaching $279.2 million. However, this figure remains below the previous year's level of $280.8 million.

Phibro Animal Health Corporation

Phibro Animal Health Corporation Demonstrates Resilient Performance with Outstanding 53.57% Increase in Earnings per Share during April to June 30, 2023 Financial Interval

The stock market has seen its fair share of ups and downs in recent times, but there is good news for investors in the Major Pharmaceutical Preparations industry. Despite a slight decline in revenue during the April to June 30, 2023 financial interval, the company managed to raise its earnings per share, resulting in an increase in profits. With a 53.57% jump in profits to $0.28 per share and a revenue decrease of just -0.34% to $254.40 million year on year, Major Pharmaceutical Preparations has shown great resilience and adaptability.
In addition to Major Pharmaceutical Preparations, the rest of the industry has also experienced a revenue rise in the fourth quarter of 2023. This positive trend indicates that the industry as a whole is showing signs of growth and potential for investors.






 

Phibro Animal Health's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com